Chunlong Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chunlong Liu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Jiangtao Yu
Department of Hepatobiliary and Pancreatic Surgery, Fuyang People’s Hospital, Fuyang, China
3 shared publications - Shijie Zhu
Department of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, China
2 shared publications Haojie Xie
Department of Neurosurgery Shengjing Hospital of China Medical University Shenyang China
1 shared publicationJiale Shao
Department of the First Clinical Medical College Anhui Medical University Hefei Anhui China
1 shared publicationJian Zhang
Department of Neurosurgery Shengjing Hospital of China Medical University Shenyang China
1 shared publication- Jian Zhang
Department of Orthopedics, Wuxi No. 2 People’s Hospital, Affiliated Wuxi Clinical College of Nantong University
1 shared publication
Latest Publications
- 26 November 2025
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 41 (2) , 813-814
Re‐Assessing the Non‐Linear Trends in the Burden of Pancreatitis From 1990 to 2021
- 26 November 2025
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 41 (2) , 813-814
Re‐Assessing the Non‐Linear Trends in the Burden of Pancreatitis From 1990 to 2021
- 23 January 2025
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 61 (6) , 1077-1079
Letter: Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Related Liver Cancer—Results From the Global Burden of Disease Study 2021
- 23 January 2025
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 61 (6) , 1077-1079
Letter: Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Related Liver Cancer—Results From the Global Burden of Disease Study 2021
- 9 January 2025
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 40 (3) , 759-760
Global Inequalities in the Burden of Gallbladder and Biliary Tract Cancer From 1990 to 2021: Findings From the Global Burden of Disease Study 2021
- 9 January 2025
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 40 (3) , 759-760
Global Inequalities in the Burden of Gallbladder and Biliary Tract Cancer From 1990 to 2021: Findings From the Global Burden of Disease Study 2021
- 14 January 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 39 (5) , 880-892
Colorectal cancer and its attributable risk factors in East Asia, 1990–2030
Background: The disease burden of colorectal cancer in East Asia has been at a high level. However, the epidemiological characteristics of the disease burden in this region have not been systematically studied.Method: Data were obtained from the Global Burden of Disease 2019 program. Joinpoint analysis was used to identify long‐term trends in mortality of colorectal cancer. Independent effects of age, period, and cohort were detected by the age–period–cohort model. The Bayesian age–period–cohort model was performed to predict the burden of colorectal cancer across East Asia by 2030.Results: From 1990 to 2019, the average annual percentage change (AAPC) showed upward trends in mainland China (1.05 [95% confidence interval (CI)], 0.82, 1.28) as well as Taiwan Province of China (1.81 [95% CI], 1.51, 2.10) but downward in Japan (−0.60 [95% CI], −0.70, −0.49) (P < 0.05). Attributable risk factors for colorectal cancer in East Asia remained stable over 30 years, while the risk of metabolic factors is noteworthy in the future. In the next decade, the age‐standardized death rate (ASDR) of colorectal cancer in China was predicted to surpass that of Japan and South Korea in expectation.Conclusion: The mortality of colorectal cancer is escalating in developing countries, while it is gradually declining in high‐income countries across East Asia. Nonetheless, the disease burden of colorectal cancer in high‐income countries remains substantial level.
- 14 January 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 39 (5) , 880-892
Colorectal cancer and its attributable risk factors in East Asia, 1990–2030
Background: The disease burden of colorectal cancer in East Asia has been at a high level. However, the epidemiological characteristics of the disease burden in this region have not been systematically studied.Method: Data were obtained from the Global Burden of Disease 2019 program. Joinpoint analysis was used to identify long‐term trends in mortality of colorectal cancer. Independent effects of age, period, and cohort were detected by the age–period–cohort model. The Bayesian age–period–cohort model was performed to predict the burden of colorectal cancer across East Asia by 2030.Results: From 1990 to 2019, the average annual percentage change (AAPC) showed upward trends in mainland China (1.05 [95% confidence interval (CI)], 0.82, 1.28) as well as Taiwan Province of China (1.81 [95% CI], 1.51, 2.10) but downward in Japan (−0.60 [95% CI], −0.70, −0.49) (P < 0.05). Attributable risk factors for colorectal cancer in East Asia remained stable over 30 years, while the risk of metabolic factors is noteworthy in the future. In the next decade, the age‐standardized death rate (ASDR) of colorectal cancer in China was predicted to surpass that of Japan and South Korea in expectation.Conclusion: The mortality of colorectal cancer is escalating in developing countries, while it is gradually declining in high‐income countries across East Asia. Nonetheless, the disease burden of colorectal cancer in high‐income countries remains substantial level.
- Open Access
- 20 April 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14
Inflammatory bowel diseases, interleukin-6 and interleukin-6 receptor subunit alpha in causal association with cerebral cortical structure: a Mendelian randomization analysis
Background: Neurological involvement and psychiatric manifestations have been documented in clinical cases of inflammatory bowel disease (IBD); however, the presence of a causal relationship remains elusive. The objective of this study is to investigate the modifications occurring in the cerebral cortex as a result of IBD.Methods: A compendium of data extracted from a genome-wide association study (GWAS) involving a maximum of 133,380 European subjects. A series of Mendelian random analyses were applied to exclude heterogeneity and pleiotropy, ensuring the stability of the results.Results: Neither IBDs nor inflammatory cytokines (IL-6/IL-6Rα) were found to have a significant causality with surface area (SA) and thickness (TH) at the global level. At the regional functional brain level, Crohn’s disease (CD) significantly decreased the TH of pars orbitalis (β=-0.003mm, Se=0.001mm, pivw =4.85×10-4). IL-6 was observed to reduce the SA of middle temporal (β=-28.575mm2, Se=6.482mm2, pivw=1.04×10-5) and increase the TH of fusiform (β=0.008mm, Se=0.002mm, pivw=8.86×10-5) and pars opercularis (β=0.009mm, Se=0.002mm, pivw=2.34×10-4). Furthermore, a causal relationship between IL-6Rα and an increase in the SA of superior frontal (β=21.132mm2, Se=5.806mm2, pivw=2.73×10-4) and the TH of supramarginal (β=0.003mm, Se=0.0002mm, pivw=7.86×10-37). All results passed sensitivity analysis and no heterogeneity and pleiotropy were detected.Conclusion: The correlation between IBD and changes in cerebral cortical structures implies the existence of a gut-brain axis at the organismal level. It is recommended that clinical patients with IBD prioritize long-term management of inflammation, as changes at the organismal level can lead to functional pathologies. Magnetic resonance imaging (MRI) may be considered as an additional screening option for IBD.
- 20 April 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14
Open AccessInflammatory bowel diseases, interleukin-6 and interleukin-6 receptor subunit alpha in causal association with cerebral cortical structure: a Mendelian randomization analysis
Background: Neurological involvement and psychiatric manifestations have been documented in clinical cases of inflammatory bowel disease (IBD); however, the presence of a causal relationship remains elusive. The objective of this study is to investigate the modifications occurring in the cerebral cortex as a result of IBD.Methods: A compendium of data extracted from a genome-wide association study (GWAS) involving a maximum of 133,380 European subjects. A series of Mendelian random analyses were applied to exclude heterogeneity and pleiotropy, ensuring the stability of the results.Results: Neither IBDs nor inflammatory cytokines (IL-6/IL-6Rα) were found to have a significant causality with surface area (SA) and thickness (TH) at the global level. At the regional functional brain level, Crohn’s disease (CD) significantly decreased the TH of pars orbitalis (β=-0.003mm, Se=0.001mm, pivw =4.85×10-4). IL-6 was observed to reduce the SA of middle temporal (β=-28.575mm2, Se=6.482mm2, pivw=1.04×10-5) and increase the TH of fusiform (β=0.008mm, Se=0.002mm, pivw=8.86×10-5) and pars opercularis (β=0.009mm, Se=0.002mm, pivw=2.34×10-4). Furthermore, a causal relationship between IL-6Rα and an increase in the SA of superior frontal (β=21.132mm2, Se=5.806mm2, pivw=2.73×10-4) and the TH of supramarginal (β=0.003mm, Se=0.0002mm, pivw=7.86×10-37). All results passed sensitivity analysis and no heterogeneity and pleiotropy were detected.Conclusion: The correlation between IBD and changes in cerebral cortical structures implies the existence of a gut-brain axis at the organismal level. It is recommended that clinical patients with IBD prioritize long-term management of inflammation, as changes at the organismal level can lead to functional pathologies. Magnetic resonance imaging (MRI) may be considered as an additional screening option for IBD.